loadpatents
name:-0.0068440437316895
name:-0.0029211044311523
name:-0.0044698715209961
PUSEY; Michelle Patent Filings

PUSEY; Michelle

Patent Applications and Registrations

Patent applications and USPTO patent grants for PUSEY; Michelle.The latest application filed is for "combination therapy comprising an alk2 inhibitor and a jak2 inhibitor".

Company Profile
3.5.7
  • PUSEY; Michelle - Wilmington DE
  • Pusey; Michelle - Bordentown NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Combination Therapy Comprising An Alk2 Inhibitor And A Jak2 Inhibitor
App 20210154195 - CHEN; Yaoyu ;   et al.
2021-05-27
Pme-1 As A Biomarker To Predict And Diagnose An Increased Risk Of Endometrial Cancer And Gene Silencing Of Pme-1 To Inhibit Epit
App 20200190592 - Rice; Lyndi ;   et al.
2020-06-18
PME-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition
Grant 10,167,472 - Rice , et al. J
2019-01-01
Pme-1 As A Biomarker To Predict And Diagnose An Increased Risk Of Endometrial Cancer And Gene Silencing Of Pme-1 To Inhibit Epithelial To Mesenchymal Transition
App 20170226520 - Rice; Lyndi ;   et al.
2017-08-10
PME-1 as a biomarker to predict and diagnose endometrial and breast cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition
Grant 9,663,789 - Rice , et al. May 30, 2
2017-05-30
PME-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition
Grant 9,657,349 - Rice , et al. May 23, 2
2017-05-23
Pme-1 As A Biomarker To Predict And Diagnose Endometrial And Breast Cancer And Gene Silencing Of Pme-1 To Inhibit Epithelial To Mesenchymal Transition
App 20150284723 - Rice; Lyndi M. ;   et al.
2015-10-08
Pme-1 As A Biomarker To Predict And Diagnose An Increased Risk Of Endometrial Cancer And Gene Silencing Of Pme-1 To Inhibit Epithelial To Mesenchymal Transition
App 20140323546 - Rice; Lyndi ;   et al.
2014-10-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed